Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 3Pleural Diseases 2Pancreatic Neoplasms 2Mesothelioma, Malignant 2Keratosis, Actinic 2Prostatic Neoplasms 1Mesothelioma 1Lung Neoplasms 1Esophageal Neoplasms 1Epitheliod Malignant Pleural Mesothelioma 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

Aminolevulinic Acid 5Fluorouracil 3tirbanibulin 2Photochemotherapy 2Niacinamide 2Cryotherapy 2methyl 5-aminolevulinate 1green tea extract polyphenone E 1dehydroftorafur 1calcipotriene 1Therapeutics 1Sunscreening Agents 1Powders 1Ointments 1Imipramine 1Control Groups 1Biopsy 1BF-200 ALA 1Aluminum Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Keratosis, Actinic × Photochemotherapy × 1 year × Clear all
NCT05923060 2026-02-20

Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses

Case Comprehensive Cancer Center

Phase 2 Completed
14 enrolled
Dermatologic

Keratosis, Actinic

NCT02373371 2025-07-29

Actinic Keratoses Treatment With Metvix® in Combination With Light

University Hospital, Limoges

Phase 3 Completed
26 enrolled 9 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡